Manifesto for Wales
Policy recommendations:
Advancing clinical trials: Bringing research to the patient
The challenge: Between 2019 and 2024, Wales hosted 120 industry sponsored cancer clinical trials, none of which were for brain cancer. Of the 681 participants recruited to trials, zero were brain cancer patients.
Research is heavily centralised in Cardiff, so patients face geographic barriers. In January 2026, of the 10 academic clinical trials for brain cancer currently active and recruiting in Wales, only one is recruiting outside of Cardiff.
Recommendations:
Mandate and fund a national strategy to advance clinical trials for rare and less common cancers beyond the Cardiff hub (the current primary oncology research centre)
Incentivise the pharmaceutical industry to set up brain tumour clinical trials in Wales by improving the speed of regulatory approvals, reducing trial start-up times and supporting effective patient recruitment
Integrating innovative tools: Whole genome sequencing (WGS)
The challenge:
WGS can improve diagnosis, identify patients suited for clinical trials and reveal mutations that guide personalised treatment, but Wales lacks routine WGS for adult brain tumour patients. With only one centre in Cardiff, some patients must travel to Liverpool, creating unequal access and delaying targeted treatments.
Recommendations:
Standardise “Cold Chain” Logistics by mandating that the neurosurgical centre in Wales be equipped with the necessary equipment to facilitate the immediate preservation of tissue samples
Include primary brain tumours in the National Genomic Test Directory for Wales to ensure clinicians can order WGS as a standard of care, rather than an exception
Implement suggested education for neurosurgical and pathology teams on the “Fresh-to-Frozen” protocol to ensure fresh frozen tissue is collected from all patients where eligible
Improve patient genomic literacy by developing accessible educational resources co-produced with patients that explain how tissue donation directly impacts their personalised treatment plan and contributes to wider research
Greater focus on funding
Health and Care Research Wales have supported only one brain tumour research project since its creation in 2015, with no new projects funded after 2022. This lack of investment slows progress in understanding and treating brain tumours, limits patient access to clinical trials and reduces the ability for Wales to attract industry investment and scientific talent.
Recommendations:
Increase targeted funding for brain tumour research opportunities provided by Health and Care Research Wales to address the current funding gap
Hold Welsh Government and Health and Care Research Wales to account for the number of brain tumour research opportunities they are funding